Information about PVpharm

PVpharm initiates a collaboration with the Leiden University Medical Center (LUMC) in the Netherlands

  • Post published:May 3, 2023

We are happy to announce that PVpharm have enter in a new agreement with Leiden University Medical Center (LUMC) to provide safety and regulatory consulting. LUMC was formed from a collaboration between the Academic Hospital Leiden and the Faculty of Medicine of Leiden University, and provides scientific and material support to first steps of the drug development in humans. As an innovator, the LUMC stands for improving healthcare and people's health. This is done on the basis of leading research and innovative education. The objective of the LUMC is to be one of the top 10 University Medical Centers in…

Continue ReadingPVpharm initiates a collaboration with the Leiden University Medical Center (LUMC) in the Netherlands
PVpharm participates in “Feria de Empleo 2023” at the University of Almería
Feria de Empleo UAL 2023

PVpharm participates in “Feria de Empleo 2023” at the University of Almería

  • Post published:April 11, 2023

PVpharm will be participating in the “Feria de Empleo 2023”, along with other companies and organizations from Almería like Cosentino, Cajamar, Kimitec, FAAM or Verdiblanca. This job fair dedicates two days in which local companies have the opportunity to make themselves known in a closer way and thus create a common space where both, the student and the company, can mutually exchange and enrich each other. -When? Monday, 17th April: 10:30 am – 2 pm 4 pm – 7 pm Tuesday, 18th April: 10 am – 14 pm -Where? The main avenue of the University of Almeria

Continue ReadingPVpharm participates in “Feria de Empleo 2023” at the University of Almería

PVpharm to provide pharmacovigilance and CTIS support to the Centre for Human Drug Research of the Netherlands (CHDR).

  • Post published:January 24, 2023

We are happy to announce that PVpharm have enter in a new agreement with Centre for Human Drug Research (CHDR) to provide safety and regulatory consulting. This prestigious foundation, based in Leiden (NL) and with three decades of history, provide scientific and material support to first steps of the drug development in humans (phase I and II of Clinical trials). Our collaboration will focus on helping about EMA’s Clinical Trial Information System (CTIS) and pharmacovigilance tasks, essential in these steps of drug development. With different therapeutic areas of research, CHDR is a leading organization in this field, with projects as…

Continue ReadingPVpharm to provide pharmacovigilance and CTIS support to the Centre for Human Drug Research of the Netherlands (CHDR).

Faculty at Signal Management training by DIA November 2022

  • Post published:November 24, 2022

On 21-24 November 2022, JosĂ© Ortiz provided the training faculty for the Signal Management training organized by DIA. This training provides knowledge over Signal Management to the participants, so they can apply the basic concepts and principles of signal detection in pharmacovigilance, from simple visualisation and tabulation methods to sophisticated data mining techniques. • Design the signal management process for institutions and companies of various sizes, portfolios and geographical presence, based on the possibilities and limitations of their data and resources • Understand key messages from the current European and US regulations on signal management, to best manage implications also…

Continue ReadingFaculty at Signal Management training by DIA November 2022
DIA QPPV forum 2022 – No slides presentation
QPPV Forum 2022

DIA QPPV forum 2022 – No slides presentation

  • Post published:November 7, 2022

JosĂ© Ortiz, PVpharm CEO, participated one more time as a speaker in the QPPV forum 2022 organized by DIA. https://www.diaglobal.org/en/conference-listing/meetings/2022/11/global-forum-for-qualified-persons-for-pharmacovigilance-qppv JosĂ© presented in the Session 2: Pharmacovigilance System Oversight on 09 Nov 2022 9:00 AM – 09 Nov 2022 10:30 AM together with other key speakers as: -Sina Schader, DrMed EU and UK QPPV Abbvie, Germany -Gabrielle Amselem Deputy EU/UK QPPV Alexion, France -Hayley Fletcher Principal Quality Lead, PDQ Quality Assurance Process GVP Roche Products Ltd., United Kingdom Session chairs were: -Gemma Jimenez Sese Patient Safety Director, EU QPPV Almirall, S.A., Spain -Kiernan Trevett, MSc Principal Quality Lead, PDQ Quality…

Continue ReadingDIA QPPV forum 2022 – No slides presentation

PVpharm at Farmaforum 2022 (Video)

  • Post published:October 18, 2022

PVpharm participated in the 2022 edition of FARMAFORUM. PVpharm presented their services. We created a VIDEO that you can see below. Pharmacovigilance and quality services GVP, GCP, GDP and GMP: As a Pharmacovigilance service provider, PVpharm offers a full range of PV services for the pharmaceutical industry, sponsors of clinical trials and other service provider companies. PVpharm also provides a risk-based Pharmacovigilance Audit Service, which focuses on the areas of highest risk to an organisation’s pharmacovigilance system, taking into account applicable local regulatory requirements. Our approach is risk and process based, our objective is to improve your pharmacovigilance system in order to…

Continue ReadingPVpharm at Farmaforum 2022 (Video)

PVpharm participates in the 2022 European Researchers’ Night

  • Post published:September 29, 2022

The European Researchers' Night is a Europe-wide public event, which displays the diversity of science and its impact on citizens' daily lives in fun, inspiring ways. This year, the event will take place in 25 countries on Friday 30 September 2022. The European Researchers' Night aims to: -bring research and researchers closer to the public-promote excellent research projects across Europe and beyond-increase the interest of young people in science and research careers-showcase the impact of researchers’ work on people’s daily lives The European Researchers’ Night attracts each year more than 1 million visitors in Europe and beyond. Juego de la…

Continue ReadingPVpharm participates in the 2022 European Researchers’ Night

Meet us at Farmaforum 4-5 October 2022!

  • Post published:September 29, 2022

PVpharm will participate as an exhibitor in the next edition of Farmaforum, one of the most important events of the Pharmaceutical Industry in Spain. The event will be held in Madrid at IFEMA on the 4th and 5th of October 2022. We are so excited and impatiently anticipating the day of the event. If you decide to visit us, we will be so happy to receive you at our stand, STAND B70, to provide you any kind of information regarding our company, services, careers, etc; or to just have a cup of coffee and share a nice talk. JosĂ© Alberto Ayala Ortiz, CEO…

Continue ReadingMeet us at Farmaforum 4-5 October 2022!
José Ortiz to participate as a speaker in the DIA QPPV forum 2022
Jose Ortiz will be presenting on the QPPV forum 2022 organized by DIA

José Ortiz to participate as a speaker in the DIA QPPV forum 2022

  • Post published:September 17, 2022

JosĂ© Ortiz, PVpharm CEO will participate one more time as a speaker in the next QPPV forum organized by DIA. You can find more information in the link: https://www.diaglobal.org/en/conference-listing/meetings/2022/11/global-forum-for-qualified-persons-for-pharmacovigilance-qppv JosĂ© will be presenting in the Session 2: Pharmacovigilance System Oversight on 09 Nov 2022 9:00 AM – 09 Nov 2022 10:30 AM https://www.diaglobal.org/en/conference-listing/meetings/2022/11/global-forum-for-qualified-persons-for-pharmacovigilance-qppv/agenda/09/session-2-pharmacovigilance-system-oversight?ref=Session2PharmacovigilanceSystemOversight About the QPPV forum: In a changing and expanding world, this is still the only forum designed for QPPVs by QPPVs, now celebrating its 16th year and still going strong. Back in a face-to-face format, it brings together QPPVs from all over the world to discuss how…

Continue ReadingJosé Ortiz to participate as a speaker in the DIA QPPV forum 2022